Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1966 1
1973 1
1974 1
1975 1
1982 2
1983 3
1984 2
1985 9
1986 8
1987 12
1988 11
1989 13
1990 14
1991 10
1992 5
1993 9
1994 16
1995 7
1996 14
1997 8
1998 13
1999 10
2000 13
2001 17
2002 20
2003 11
2004 18
2005 28
2006 29
2007 45
2008 44
2009 53
2010 55
2011 65
2012 57
2013 60
2014 52
2015 60
2016 52
2017 54
2018 61
2019 60
2020 51
2021 64
2022 72
2023 60
2024 54

Text availability

Article attribute

Article type

Publication date

Search Results

1,201 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
Lorusso D, Xiang Y, Hasegawa K, Scambia G, Leiva M, Ramos-Elias P, Acevedo A, Sukhin V, Cloven N, Pereira de Santana Gomes AJ, Contreras Mejía F, Reiss A, Ayhan A, Lee JY, Saevets V, Zagouri F, Gilbert L, Sehouli J, Tharavichitkul E, Lindemann K, Lazzari R, Chang CL, Lampé R, Zhu H, Oaknin A, Christiaens M, Polterauer S, Usami T, Li K, Yamada K, Toker S, Keefe SM, Pignata S, Duska LR; ENGOT-cx11/GOG-3047/KEYNOTE-A18 investigators. Lorusso D, et al. Among authors: chang cl. Lancet. 2024 Apr 6;403(10434):1341-1350. doi: 10.1016/S0140-6736(24)00317-9. Epub 2024 Mar 20. Lancet. 2024. PMID: 38521086 Clinical Trial.
How to Prevent Atopic Dermatitis (Eczema) in 2024: Theory and Evidence.
Chu DK, Koplin JJ, Ahmed T, Islam N, Chang CL, Lowe AJ. Chu DK, et al. Among authors: chang cl. J Allergy Clin Immunol Pract. 2024 Jul;12(7):1695-1704. doi: 10.1016/j.jaip.2024.04.048. Epub 2024 May 2. J Allergy Clin Immunol Pract. 2024. PMID: 38703820 Free article. Review.
Lipoprotein lipase: new roles for an 'old' enzyme.
Chang CL. Chang CL. Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):111-115. doi: 10.1097/MCO.0000000000000536. Curr Opin Clin Nutr Metab Care. 2019. PMID: 30648986 Free PMC article. Review.
Cotton-based diagnostic devices.
Lin SC, Hsu MY, Kuan CM, Wang HK, Chang CL, Tseng FG, Cheng CM. Lin SC, et al. Among authors: chang cl. Sci Rep. 2014 Nov 13;4:6976. doi: 10.1038/srep06976. Sci Rep. 2014. PMID: 25393975 Free PMC article.
Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin Attenuates Sorafenib-Induced Myocardial Inflammation and Toxicity.
Liu CH, Ho YC, Lee WC, Huang CY, Lee YK, Hsieh CB, Huang NC, Wu CC, Nguyen NUN, Hsu CC, Chen CH, Chen YC, Huang WC, Lu YY, Fang CC, Chang YC, Chang CL, Tsai MK, Wen ZH, Li CZ, Li CC, Chuang PK, Yang SM, Chu TH, Huang SC. Liu CH, et al. Among authors: chang cl. Environ Toxicol. 2024 Jun 17. doi: 10.1002/tox.24362. Online ahead of print. Environ Toxicol. 2024. PMID: 38884142
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lorusso D, Xiang Y, Hasegawa K, Scambia G, Leiva M, Ramos-Elias P, Acevedo A, Cvek J, Randall L, Pereira de Santana Gomes AJ, Contreras Mejía F, Helpman L, Akıllı H, Lee JY, Saevets V, Zagouri F, Gilbert L, Sehouli J, Tharavichitkul E, Lindemann K, Colombo N, Chang CL, Bednarikova M, Zhu H, Oaknin A, Christiaens M, Petru E, Usami T, Liu P, Yamada K, Toker S, Keefe SM, Pignata S, Duska LR; ENGOT-cx11/GOG-3047/KEYNOTE-A18 investigators. Lorusso D, et al. Among authors: chang cl. Lancet. 2024 Oct 5;404(10460):1321-1332. doi: 10.1016/S0140-6736(24)01808-7. Epub 2024 Sep 14. Lancet. 2024. PMID: 39288779 Clinical Trial.
1,201 results